Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4170612
Max Phase: Preclinical
Molecular Formula: C27H40N2O2S
Molecular Weight: 456.70
Molecule Type: Small molecule
Associated Items:
ID: ALA4170612
Max Phase: Preclinical
Molecular Formula: C27H40N2O2S
Molecular Weight: 456.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]2(O)CNC(=S)Nc1ccccc1
Standard InChI: InChI=1S/C27H40N2O2S/c1-25-13-10-20(30)16-18(25)8-9-21-22(25)11-14-26(2)23(21)12-15-27(26,31)17-28-24(32)29-19-6-4-3-5-7-19/h3-7,18,20-23,30-31H,8-17H2,1-2H3,(H2,28,29,32)/t18-,20-,21+,22-,23-,25-,26-,27+/m0/s1
Standard InChI Key: IEAFZCHPFVSGFO-ACEZCWTCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 456.70 | Molecular Weight (Monoisotopic): 456.2810 | AlogP: 5.11 | #Rotatable Bonds: 3 |
Polar Surface Area: 64.52 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.34 | CX Basic pKa: | CX LogP: 4.95 | CX LogD: 4.95 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.48 | Np Likeness Score: 0.96 |
1. Romero-Hernández LL, Merino-Montiel P, Meza-Reyes S, Vega-Baez JL, López Ó, Padrón JM, Montiel-Smith S.. (2018) Synthesis of unprecedented steroidal spiro heterocycles as potential antiproliferative drugs., 143 [PMID:29172080] [10.1016/j.ejmech.2017.10.063] |
Source(1):